Chris Boerner

Track

Insider profile

Currently holds a position at Bristol-Myers Squibb Co

Performance

Overall performance
2.0
Performance over holding periods
2.0
30 days 90 days 120 days
Average return -9% 8.2% 15.1%
Success rate 15% 68% 82%
Transactions
4 75% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Executive Vice President and Chief Commercial Officer Bristol-Myers Squibb Co Aug. 28, 2018 -
Independent Director Achaogen Inc March 27, 2015 - June 10, 2015
Executive Vice President - Commercial Seagen Inc Feb. 10, 2014 - Jan. 30, 2015
Senior Vice President - Commercial Seagen Inc March 1, 2012 - Feb. 10, 2014
Chris Boerner's trades of Bristol-Myers Squibb Co's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
363.52
Quantity 60,840 +10.9%
Value US$71,409
Transaction date
Purchase
Price
400.42
Quantity 61,649 -35.9%
Value US$4,450,745
Transaction date
Purchase
Price
24.12
Quantity 3,818 -27.7%
Value US$4,566,700
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-21 2025-02-20
B Purchase
60,840 +10.9%
363.52
US$71,409 		60,840 +10.9% 363.52 US$71,409
2023-12-07 2023-12-05
B Purchase
61,649 -35.9%
400.42
US$4,450,745 		61,649 -35.9% 400.42 US$4,450,745
2023-11-30 2023-11-28
B Purchase
3,818 -27.7%
24.12
US$4,566,700 		3,818 -27.7% 24.12 US$4,566,700
2022-03-16 2022-03-14
S Sale
29,532 -41.3%
69.20
US$2,043,526 		29,532 -41.3% 69.20 US$2,043,526